Comprehensive Echocardiographic Assessment of Normal Transcatheter Valve Function

Rebecca T. Hahn, Jonathon Leipsic, Pamela S. Douglas, Wael A. Jaber, Neil J. Weissman, Philippe Pibarot, Philipp Blanke, Jae Kuen Oh

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Objectives: This study aims to establish parameters for identifying normal function for each of the 3 iterations of balloon-expandable valves and 2 iterations of self-expanding valves. Background: Expected transthoracic echocardiographic Doppler-derived hemodynamic data for transcatheter aortic valves inform pre-implant decision-making and post-implanted monitoring of longitudinal valve function. Methods: We collected the Echocardiography Core Lab measured mean gradients and effective orifice area (EOA) from discharge or 30-day echocardiograms from randomized trials; the PARTNER (Placement of Aortic Transcatheter Valves) trials for the balloon-expandable valves and the Medtronic CoreValve US Pivotal trial and Medtronic CoreValve Evolut R United States IDE Clinical Study for the self-expanding valves. Results: For all SAPIEN (Edwards Lifesciences, Irvine, California) valve sizes, mean EOA = 1.70 ± 0.49 cm2 with mean gradient of 9.36 ± 4.13 mm Hg. For all SAPIEN XT valve sizes, mean EOA = 1.67 ± 0.46 cm2 with mean gradient of 9.52 ± 3.64 mm Hg. For all SAPIEN 3 valve sizes, the mean EOA = 1.66 ± 0.38 cm2 with mean gradient of 11.18 ± 4.35 mm Hg. For all CoreValve valve sizes, the mean EOA = 1.88 ± 0.56 cm2 with mean gradient of 8.85 ± 4.14 mm Hg. For all Evolut R valve sizes, the mean EOA = 2.01 ± 0.65 cm2 with mean gradient of 7.52 ± 3.19 mm Hg. The SAPIEN 3 post-implant EOA was progressively larger for each quintile of baseline annular area by computed tomography (p < 0.001). Similarly, for the Evolut R valve, post-implantation EOA was significantly larger for each quintile of baseline annular perimeter (p < 0.001). Conclusions: Tables of expected mean transcatheter aortic valve hemodynamics by valve type and size are essential in evaluating the function of these transcatheter prosthetic valves. Tables of expected EOA by the native annular anatomy may be useful for pre-implantation decision making. Criteria for defining structural valve dysfunction are proposed.

Original languageEnglish (US)
JournalJACC: Cardiovascular Imaging
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Aortic Valve
Decision Making
Hemodynamics
Echocardiography
Anatomy
Tomography

Keywords

  • echocardiography
  • effective orifice area
  • hemodynamics
  • transcatheter aortic valve replacement

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Comprehensive Echocardiographic Assessment of Normal Transcatheter Valve Function. / Hahn, Rebecca T.; Leipsic, Jonathon; Douglas, Pamela S.; Jaber, Wael A.; Weissman, Neil J.; Pibarot, Philippe; Blanke, Philipp; Oh, Jae Kuen.

In: JACC: Cardiovascular Imaging, 01.01.2018.

Research output: Contribution to journalArticle

Hahn, Rebecca T. ; Leipsic, Jonathon ; Douglas, Pamela S. ; Jaber, Wael A. ; Weissman, Neil J. ; Pibarot, Philippe ; Blanke, Philipp ; Oh, Jae Kuen. / Comprehensive Echocardiographic Assessment of Normal Transcatheter Valve Function. In: JACC: Cardiovascular Imaging. 2018.
@article{f6e6f02a3f0e42cd8b323684c9217516,
title = "Comprehensive Echocardiographic Assessment of Normal Transcatheter Valve Function",
abstract = "Objectives: This study aims to establish parameters for identifying normal function for each of the 3 iterations of balloon-expandable valves and 2 iterations of self-expanding valves. Background: Expected transthoracic echocardiographic Doppler-derived hemodynamic data for transcatheter aortic valves inform pre-implant decision-making and post-implanted monitoring of longitudinal valve function. Methods: We collected the Echocardiography Core Lab measured mean gradients and effective orifice area (EOA) from discharge or 30-day echocardiograms from randomized trials; the PARTNER (Placement of Aortic Transcatheter Valves) trials for the balloon-expandable valves and the Medtronic CoreValve US Pivotal trial and Medtronic CoreValve Evolut R United States IDE Clinical Study for the self-expanding valves. Results: For all SAPIEN (Edwards Lifesciences, Irvine, California) valve sizes, mean EOA = 1.70 ± 0.49 cm2 with mean gradient of 9.36 ± 4.13 mm Hg. For all SAPIEN XT valve sizes, mean EOA = 1.67 ± 0.46 cm2 with mean gradient of 9.52 ± 3.64 mm Hg. For all SAPIEN 3 valve sizes, the mean EOA = 1.66 ± 0.38 cm2 with mean gradient of 11.18 ± 4.35 mm Hg. For all CoreValve valve sizes, the mean EOA = 1.88 ± 0.56 cm2 with mean gradient of 8.85 ± 4.14 mm Hg. For all Evolut R valve sizes, the mean EOA = 2.01 ± 0.65 cm2 with mean gradient of 7.52 ± 3.19 mm Hg. The SAPIEN 3 post-implant EOA was progressively larger for each quintile of baseline annular area by computed tomography (p < 0.001). Similarly, for the Evolut R valve, post-implantation EOA was significantly larger for each quintile of baseline annular perimeter (p < 0.001). Conclusions: Tables of expected mean transcatheter aortic valve hemodynamics by valve type and size are essential in evaluating the function of these transcatheter prosthetic valves. Tables of expected EOA by the native annular anatomy may be useful for pre-implantation decision making. Criteria for defining structural valve dysfunction are proposed.",
keywords = "echocardiography, effective orifice area, hemodynamics, transcatheter aortic valve replacement",
author = "Hahn, {Rebecca T.} and Jonathon Leipsic and Douglas, {Pamela S.} and Jaber, {Wael A.} and Weissman, {Neil J.} and Philippe Pibarot and Philipp Blanke and Oh, {Jae Kuen}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jcmg.2018.04.010",
language = "English (US)",
journal = "JACC: Cardiovascular Imaging",
issn = "1936-878X",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Comprehensive Echocardiographic Assessment of Normal Transcatheter Valve Function

AU - Hahn, Rebecca T.

AU - Leipsic, Jonathon

AU - Douglas, Pamela S.

AU - Jaber, Wael A.

AU - Weissman, Neil J.

AU - Pibarot, Philippe

AU - Blanke, Philipp

AU - Oh, Jae Kuen

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objectives: This study aims to establish parameters for identifying normal function for each of the 3 iterations of balloon-expandable valves and 2 iterations of self-expanding valves. Background: Expected transthoracic echocardiographic Doppler-derived hemodynamic data for transcatheter aortic valves inform pre-implant decision-making and post-implanted monitoring of longitudinal valve function. Methods: We collected the Echocardiography Core Lab measured mean gradients and effective orifice area (EOA) from discharge or 30-day echocardiograms from randomized trials; the PARTNER (Placement of Aortic Transcatheter Valves) trials for the balloon-expandable valves and the Medtronic CoreValve US Pivotal trial and Medtronic CoreValve Evolut R United States IDE Clinical Study for the self-expanding valves. Results: For all SAPIEN (Edwards Lifesciences, Irvine, California) valve sizes, mean EOA = 1.70 ± 0.49 cm2 with mean gradient of 9.36 ± 4.13 mm Hg. For all SAPIEN XT valve sizes, mean EOA = 1.67 ± 0.46 cm2 with mean gradient of 9.52 ± 3.64 mm Hg. For all SAPIEN 3 valve sizes, the mean EOA = 1.66 ± 0.38 cm2 with mean gradient of 11.18 ± 4.35 mm Hg. For all CoreValve valve sizes, the mean EOA = 1.88 ± 0.56 cm2 with mean gradient of 8.85 ± 4.14 mm Hg. For all Evolut R valve sizes, the mean EOA = 2.01 ± 0.65 cm2 with mean gradient of 7.52 ± 3.19 mm Hg. The SAPIEN 3 post-implant EOA was progressively larger for each quintile of baseline annular area by computed tomography (p < 0.001). Similarly, for the Evolut R valve, post-implantation EOA was significantly larger for each quintile of baseline annular perimeter (p < 0.001). Conclusions: Tables of expected mean transcatheter aortic valve hemodynamics by valve type and size are essential in evaluating the function of these transcatheter prosthetic valves. Tables of expected EOA by the native annular anatomy may be useful for pre-implantation decision making. Criteria for defining structural valve dysfunction are proposed.

AB - Objectives: This study aims to establish parameters for identifying normal function for each of the 3 iterations of balloon-expandable valves and 2 iterations of self-expanding valves. Background: Expected transthoracic echocardiographic Doppler-derived hemodynamic data for transcatheter aortic valves inform pre-implant decision-making and post-implanted monitoring of longitudinal valve function. Methods: We collected the Echocardiography Core Lab measured mean gradients and effective orifice area (EOA) from discharge or 30-day echocardiograms from randomized trials; the PARTNER (Placement of Aortic Transcatheter Valves) trials for the balloon-expandable valves and the Medtronic CoreValve US Pivotal trial and Medtronic CoreValve Evolut R United States IDE Clinical Study for the self-expanding valves. Results: For all SAPIEN (Edwards Lifesciences, Irvine, California) valve sizes, mean EOA = 1.70 ± 0.49 cm2 with mean gradient of 9.36 ± 4.13 mm Hg. For all SAPIEN XT valve sizes, mean EOA = 1.67 ± 0.46 cm2 with mean gradient of 9.52 ± 3.64 mm Hg. For all SAPIEN 3 valve sizes, the mean EOA = 1.66 ± 0.38 cm2 with mean gradient of 11.18 ± 4.35 mm Hg. For all CoreValve valve sizes, the mean EOA = 1.88 ± 0.56 cm2 with mean gradient of 8.85 ± 4.14 mm Hg. For all Evolut R valve sizes, the mean EOA = 2.01 ± 0.65 cm2 with mean gradient of 7.52 ± 3.19 mm Hg. The SAPIEN 3 post-implant EOA was progressively larger for each quintile of baseline annular area by computed tomography (p < 0.001). Similarly, for the Evolut R valve, post-implantation EOA was significantly larger for each quintile of baseline annular perimeter (p < 0.001). Conclusions: Tables of expected mean transcatheter aortic valve hemodynamics by valve type and size are essential in evaluating the function of these transcatheter prosthetic valves. Tables of expected EOA by the native annular anatomy may be useful for pre-implantation decision making. Criteria for defining structural valve dysfunction are proposed.

KW - echocardiography

KW - effective orifice area

KW - hemodynamics

KW - transcatheter aortic valve replacement

UR - http://www.scopus.com/inward/record.url?scp=85048566445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048566445&partnerID=8YFLogxK

U2 - 10.1016/j.jcmg.2018.04.010

DO - 10.1016/j.jcmg.2018.04.010

M3 - Article

C2 - 29909110

AN - SCOPUS:85048566445

JO - JACC: Cardiovascular Imaging

JF - JACC: Cardiovascular Imaging

SN - 1936-878X

ER -